Smith Robert Joseph

Smith Robert Joseph is listed in filings as Director at Citius Oncology, Inc.. This profile follows SEC Form 4 activity through Sep 23, 2025, including 3 public disclosures. Recent filings connect the profile to Citius Oncology, Inc. (CTOR) and Citius Pharmaceuticals, Inc. (CTXR). The current snapshot covers public activity from Nov 12, 2024 to Sep 23, 2025. Reported amounts are shown as $133.8K to $47.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.